Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Citi
Federal Trade Commission
UBS
Argus Health
Cipla
Moodys
Chinese Patent Office
Dow

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203052

« Back to Dashboard

Summary for 203052
Tradename:LEVETIRACETAM
Applicant:Hetero Labs Ltd Iii
Ingredient:levetiracetam
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 203052
Suppliers and Packaging for NDA: 203052
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVETIRACETAM levetiracetam SOLUTION;ORAL 203052 ANDA Camber Pharmaceuticals, Inc. 31722-574 N 31722-574-47
LEVETIRACETAM levetiracetam SOLUTION;ORAL 203052 ANDA American Health Packaging 60687-249 N 60687-249-67

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength100MG/ML
Approval Date:Feb 28, 2013TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
McKesson
Moodys
Cantor Fitzgerald
Fuji
Daiichi Sankyo
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.